| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | brivanib | CTRPv2 | pan-cancer | AAC | 0.02 | 0.6 |
| mRNA | simvastatin | CTRPv2 | pan-cancer | AAC | -0.022 | 0.6 |
| mRNA | LE-135 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |
| mRNA | neopeltolide | CTRPv2 | pan-cancer | AAC | -0.039 | 0.6 |
| mRNA | R428 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.6 |
| mRNA | PL-DI | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | Crizotinib | CTRPv2 | pan-cancer | AAC | 0.018 | 0.6 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.019 | 0.6 |
| mRNA | IPR-456 | CTRPv2 | pan-cancer | AAC | -0.021 | 0.6 |